dm+d

407149009

New Medicines

AliniaInfluenza H1N1 strain

Information

Alinia
New molecular entity
Romark
Romark

Development and Regulatory status

None
None
Phase III Clinical Trials

Category

Inhibits haemagglutinin & modulates host cell signalling pathways involved in defence against viruses
Up to 15% of the population can develop influenza in any year. There is a 10-20% seroconversion rate with or without symptoms. In an average year, there are 50-200 GP consultations for influenza or flu-like illnesses per 100,000 population per week (patient.co.uk)
Influenza H1N1 strain
Oral

Evidence based evaluations

Alinia Common cold due to enterovirus or rhinovirus infection in patients aged 12 years and older

Information

Alinia
Licence extension / variation
Romark
Romark

Development and Regulatory status

None
None
Phase III Clinical Trials

Category

Inhibits haemagglutinin & modulates host cell signalling pathways involved in defence against viruses
The common cold can affect all population groups. It is most common in children and is especially common in younger children. Adults experience an average of 2-3 colds per year, whilst children experience an average of 5-6 colds per year [1].
Common cold due to enterovirus or rhinovirus infection in patients aged 12 years and older
Oral